Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zoetis    ZTS

ZOETIS

(ZTS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/18/2020 02/19/2020 02/20/2020 02/21/2020 02/24/2020 Date
143.65(c) 144.06(c) 143.55(c) 142.23(c) 138.39(c) Last
2 461 710 1 676 561 1 182 574 1 755 261 1 642 254 Volume
-0.36% +0.29% -0.35% -0.92% -2.70% Change
More quotes
Financials (USD)
Sales 2020 6 731 M
EBIT 2020 2 591 M
Net income 2020 1 713 M
Debt 2020 3 687 M
Yield 2020 0,54%
Sales 2021 7 225 M
EBIT 2021 2 879 M
Net income 2021 1 957 M
Debt 2021 2 670 M
Yield 2021 0,63%
P/E ratio 2020 38,0x
P/E ratio 2021 32,6x
EV / Sales2020 10,3x
EV / Sales2021 9,47x
Capitalization 65 726 M
More Financials
Company
Zoetis specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (50.2%): cats and dogs (93.8% of net sales) and horses (6.2%); - livestock (48.4%): cattle (54.6% of sales), swine (20.2%), poultry (18.4%), fish (4.4%) and... 
Sector
Pharmaceuticals
Calendar
02/24 | 08:40amPresentation
More about the company
Surperformance© ratings of Zoetis
Trading Rating : Investor Rating :
More Ratings
Latest news on ZOETIS
02/21ZOETIS : to Participate in the Cowen and Company 40th Annual Health Care Confere..
BU
02/13ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
AQ
02/13ZOETIS' : Adjusted Earnings, Revenue for 4Q Beat Analysts' Expectations
DJ
02/13ZOETIS' : Adjusted Earnings Guidance for 2020 Is Short of Analysts' Estimates
DJ
02/13ZOETIS : 4Q Earnings Snapshot
AQ
02/13ZOETIS INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
02/13ZOETIS : Reports Fourth Quarter and Full Year 2019 Results
BU
02/13ZOETIS : Annual results
CO
02/11ZOETIS INC. : Regulation FD Disclosure (form 8-K)
AQ
02/11ZOETIS : Declares Second Quarter 2020 Dividend
BU
02/10ZOETIS : annual earnings release
02/10ZOETIS : to Participate in the Bank of America Merrill Lynch Animal Health Summi..
BU
02/07ZOETIS : Acquires Ethos Diagnostic Science
DJ
02/07ZOETIS : Acquires Ethos Diagnostic Science, a Veterinary Reference Lab Business,..
BU
01/02ZOETIS : to Host Webcast and Conference Call on Fourth Quarter and Full Year 201..
BU
More news
News in other languages on ZOETIS
02/10ZOETIS : publication des résultats annuels
02/10ZOETIS : Veröffentlichung des Jahresergebnisses
2019STOCK MARKET PARIS : Trump et Xi cherchent une terre d'accueil
2019Auf den Hund gekommen - Biotecharzneien für Haustiere auf dem Vormarsch
2019Bayer verkauft Tiermedizin für 7,6 Milliarden Dollar
More news
Analyst Recommendations on ZOETIS
More recommendations
Sector news : Veterinary Drugs
02/24J&J, Sanofi, Inovio Hunt for Coronavirus Vaccines
DJ
02/24Grain Futures Fall as Coronavirus Spreads
DJ
02/24NOVARTIS : FDA, EMA Accept Filings for Ofatumumab in Relapsing Multiple Sclerosi..
DJ
02/24LONZA : France's Sanofi to carve out active drug ingredients business
RE
02/24SANOFI : to Create Pharmaceutical Ingredients Leader With Eyes to Spinoff
DJ
More sector news : Veterinary Drugs
Chart ZOETIS
Duration : Period :
Zoetis Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZOETIS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 147,40  $
Last Close Price 138,39  $
Spread / Highest target 17,1%
Spread / Average Target 6,51%
Spread / Lowest Target -27,7%
EPS Revisions
Managers
NameTitle
Kristin C. Peck Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Glenn C. David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Andrew Fenton Chief Digital & Technology Officer, Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS4.56%65 726
ELANCO ANIMAL HEALTH INCORPORATED1.90%12 397
DECHRA PHARMACEUTICALS PLC-4.00%3 735
JINYU BIO-TECHNOLOGY CO., LTD.49.34%3 655
VIRBAC-4.44%2 216
PHIBRO ANIMAL HEALTH CORPORATION4.03%1 088